Ozempic Side Effects
Ozempic Gastroparesis:
Stomach Paralysis,
Symptoms & Lawsuit Guide
Reviewed by: ClaimCheckUSA Medical & Legal TeamLast updated: March 26, 2026Reading time: 9 min
Key Facts
- A 2023 JAMA study found GLP-1 users had 9.09× higher risk of gastroparesis than non-users
- Over 10,000 Ozempic/Wegovy lawsuits have been filed in the Eastern District of Pennsylvania MDL
- Gastroparesis can cause severe malnutrition, hospitalisation, and permanent disability
- Novo Nordisk's label mentioned 'delayed gastric emptying' but did not specifically warn of gastroparesis
- Settlements are expected to range from $100,000 to $500,000+ for severe cases
Gastroparesis Symptoms
Severe nausea and vomiting
Common
Feeling full after eating small amounts
Common
Bloating and abdominal pain
Common
Heartburn and acid reflux
Common
Unintended weight loss
Moderate
Malnutrition and dehydration
Severe
Blood sugar fluctuations
Severe
Bezoar formation (food mass in stomach)
Severe
Aspiration pneumonia
Life-threatening
Aspiration Risk During Surgery
Patients with Ozempic-induced delayed gastric emptying face a serious risk of aspiration pneumonia during surgery. The FDA issued a warning in 2023 advising patients to stop GLP-1 drugs before elective procedures. Several deaths have been linked to aspiration of stomach contents during anaesthesia in patients who were not warned to stop their medication.
Treatment Options for Gastroparesis
Dietary modifications
Small, frequent meals; low-fat, low-fibre foods; liquid diet in severe cases
Metoclopramide (Reglan)
Prokinetic drug to speed gastric emptying; FDA black box warning for long-term use
Domperidone
Prokinetic agent; not FDA-approved but available through compassionate use
Erythromycin
Antibiotic with prokinetic properties; short-term use only
Gastric electrical stimulation
Surgically implanted device (gastric pacemaker) for severe refractory cases
Jejunostomy tube (J-tube)
Feeding tube bypassing the stomach for severe malnutrition
Total parenteral nutrition (TPN)
IV nutrition for patients who cannot tolerate any oral or tube feeding
Suffered Gastroparesis from Ozempic?
Check your eligibility for compensation in 60 seconds. Free case evaluation. No fees unless you win.
Check My EligibilityFrequently Asked Questions
What is gastroparesis and how does Ozempic cause it?
Gastroparesis is a condition where the stomach muscles stop working properly, preventing the stomach from emptying food into the small intestine at a normal rate. Ozempic (semaglutide) and other GLP-1 receptor agonists slow gastric emptying as part of their mechanism — this is intentional and contributes to weight loss. However, in some patients, this slowing becomes severe and permanent, resulting in clinical gastroparesis.
Is Ozempic-induced gastroparesis permanent?
In some patients, gastroparesis resolves after stopping the medication. However, many patients report persistent symptoms even after discontinuing Ozempic. Research published in JAMA in 2023 found that GLP-1 users had significantly higher rates of gastroparesis compared to non-users, suggesting the condition can be long-lasting.
Did Novo Nordisk warn patients about gastroparesis?
This is central to the lawsuits. Plaintiffs allege that Novo Nordisk and Eli Lilly knew or should have known about the risk of gastroparesis and failed to adequately warn patients and healthcare providers. The FDA label mentioned 'delayed gastric emptying' but critics argue this did not adequately convey the risk of clinical gastroparesis.
What evidence do I need to prove Ozempic caused my gastroparesis?
You need: (1) prescription records showing you took Ozempic/Wegovy/semaglutide; (2) medical records showing a gastroparesis diagnosis (typically confirmed by gastric emptying study); (3) medical records showing the diagnosis occurred after starting the medication; (4) documentation of treatment and impact on daily life.
Can I still file a lawsuit if my gastroparesis improved after stopping Ozempic?
Yes. Even if your symptoms improved after stopping the drug, you may have a valid claim for the medical expenses, lost wages, and pain and suffering you experienced during the period of illness. Hospitalisation records and treatment costs are key evidence.